Carna Biosciences

16 articles about Carna Biosciences

• 

  Brickell Looks to “STING” Autoimmune and Inflammatory Diseases with Carna Por...

  2/2/2022

  The portfolio of STING inhibitors is designed to treat autoimmune and inflammatory diseases.

• Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences

  2/2/2022

  Brickell Biotech, Inc. today announced that they have entered into a licensing agreement, whereby Brickell will have the exclusive, worldwide rights to develop and commercialize Carna’s portfolio of novel, potent, and orally available Stimulator of Interferon Genes (STING) antagonists.

• SeraNovo Enters into a Second License Agreement with Carna Biosciences for Development of Oral Formulation of Carna’s Kinase Inhibitor

  5/26/2020

  SeraNovo B.V. today announced that it has signed a second License Agreement with Carna Biosciences, Inc., a company engaged in the drug development of kinase inhibitors.

• SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor

  10/30/2019

  SeraNovo B.V. announced that it has signed a License Agreement with Carna Biosciences, Inc., a company engaged in drug development specializing in the development of kinase inhibitors.

• Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies

  6/25/2019

  Gilead Sciences, Inc. and Carna Biosciences Inc. announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule compounds in immuno-oncology and to access Carna’s proprietary lipid kinase drug discovery platform.

• SARomics Biostructures Signs Exclusive Distribution Agreement With Carna Biosciences

  8/25/2016

• Carna Biosciences Cancels Deal With Janssen Biotech Due to Strategy Reasons

  8/5/2016

• Carna Biosciences Announces Collaboration With Johnson & Johnson Innovation

  6/11/2015

• TCG Lifesciences and Carna Biosciences Enter into Strategic Alliance for 'Kinase' Based Drug Discovery Services

  10/12/2010

• Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences

  8/8/2008

• Carna Biosciences Signs Distribution Agreements To Expand Businesses In Europe

  8/4/2006

• Carna Biosciences And Enamine Ltd. Sign Collaboration Agreement

  5/17/2006

• Carna Biosciences And ChemDiv, Inc. To Collaborate In Creating And Marketing Annotated Kinase-Focused Library

  4/5/2006

• ChemDiv, Inc. And Carna Biosciences Form Strategic Alliance To Develop And Market Annotated Kinase Focused Library

  3/29/2006

• OncoTherapy Science, Inc., Carna Biosciences, And CrystalGenomics To Collaborate In Development Of Low-Molecular Drug For Cancer

  2/1/2006

• Carna Biosciences And CrystalGenomics To Collaborate In Drug Candidate Development

  6/10/2004